Symptomtext
acthib vaccine was administered that was later noted to have expired 4 days previously with no reported adverse event; Initial information received on 31-Oct-2022 regarding an unsolicited valid non-serious case from a consumer/non-hcp. This case involves 18 months old male patient to whom HIB (PRP/T) VACCINE [ACT-HIB] was administered that was later noted to have expired 4 days previously with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Daptacel) and Hepatitis A Vaccine (Hepatitis A) both for Immunisation. On 28-Oct-2022, the patient received suspect HIB (PRP/T) VACCINE at a dose of 0.5 ml once(lot UJ588AA, expiry date: 24-Oct-2022, expired 4 days previously) via intramuscular route in unknown administration site for immunization. On 28-Oct-2022 the acthib vaccine was administered that was later noted to have expired 4 days previously with no reported adverse event (expired product administered) (same day latency). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.